Index RUT
P/E -
EPS (ttm) -2.34
Insider Own 4.24%
Shs Outstand 50.14M
Perf Week 5.08%
Market Cap 384.05M
Forward P/E -
EPS next Y -0.76
Insider Trans -18.16%
Shs Float 48.01M
Perf Month 31.16%
Enterprise Value 418.96M
PEG -
EPS next Q -0.27
Inst Own 93.07%
Short Float 5.08%
Perf Quarter 24.35%
Income -115.84M
P/S 1.79
EPS this Y 59.36%
Inst Trans -2.88%
Short Ratio 4.80
Perf Half Y -2.42%
Sales 214.83M
P/B 1.06
EPS next Y 24.77%
ROA -12.77%
Short Interest 2.44M
Perf YTD -1.54%
Book/sh 7.23
P/C 1.57
EPS next 5Y 34.38%
ROE -24.08%
52W High 9.77 -21.64%
Perf Year 19.87%
Cash/sh 4.87
P/FCF -
EPS past 3/5Y 26.16% -35.29%
ROIC -18.59%
52W Low 4.58 67.25%
Perf 3Y -74.23%
Dividend Est. -
EV/EBITDA -
Sales past 3/5Y 0.86% 46.42%
Gross Margin 37.54%
Volatility 5.81% 6.65%
Perf 5Y -74.03%
Dividend TTM -
EV/Sales 1.95
EPS Y/Y TTM 5.24%
Oper. Margin -27.86%
ATR (14) 0.44
Perf 10Y 9.43%
Dividend Ex-Date -
Quick Ratio 5.24
Sales Y/Y TTM -4.53%
Profit Margin -53.92%
RSI (14) 64.06
Recom 1.67
Dividend Gr. 3/5Y - -
Current Ratio 5.56
EPS Q/Q 34.33%
SMA20 9.22%
Beta 1.88
Target Price 11.44
Payout -
Debt/Eq 0.61
Sales Q/Q -24.82%
SMA50 18.28%
Rel Volume 0.38
Prev Close 7.44
Employees 1186
LT Debt/Eq 0.56
Earnings May 07 AMC
SMA200 10.27%
Avg Volume 507.94K
Price 7.66
IPO Jan 31, 2005
Option/Short Yes / Yes
EPS/Sales Surpr. 18.84% 2.07%
Trades
Volume 190,914
Change 2.96%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-24-25 Upgrade
UBS
Neutral → Buy
$10
Dec-19-24 Initiated
Guggenheim
Buy
$11
Aug-07-24 Downgrade
Jefferies
Buy → Hold
$20 → $8
Jul-31-24 Upgrade
B. Riley Securities
Neutral → Buy
$19 → $15
May-03-24 Downgrade
B. Riley Securities
Buy → Neutral
$22 → $19
Apr-04-24 Resumed
Jefferies
Buy
$17 → $21
Mar-13-24 Reiterated
Needham
Buy
$19 → $18
Aug-17-23 Initiated
Morgan Stanley
Equal-Weight
$16
Aug-10-23 Downgrade
Stephens
Overweight → Equal-Weight
$15
Jul-18-23 Downgrade
UBS
Buy → Neutral
$28 → $17
Jul-17-23 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Jul-13-23 Downgrade
SVB Securities
Outperform → Market Perform
$30 → $10
Jan-19-22 Upgrade
ROTH Capital
Neutral → Buy
$90
Nov-05-21 Downgrade
ROTH Capital
Buy → Neutral
$78 → $90
Oct-19-21 Resumed
B. Riley Securities
Buy
$81
Jul-16-21 Initiated
BTIG Research
Buy
$80
Mar-15-21 Initiated
UBS
Buy
$84
Mar-02-21 Resumed
Needham
Buy
$73
Nov-10-20 Initiated
KeyBanc Capital Markets
Overweight
$54
Jan-08-20 Initiated
Stephens
Overweight
$21
Show Previous Ratings
Jul-04-25 12:00PM
Jun-27-25 12:00PM
Jun-12-25 08:00AM
May-28-25 09:55AM
May-12-25 09:55AM
03:34AM
Loading…
May-08-25 03:34AM
May-07-25 07:15PM
07:15PM
05:20PM
04:05PM
May-06-25 09:35AM
Apr-30-25 10:01AM
Apr-24-25 08:30AM
Apr-10-25 10:39AM
Apr-04-25 06:03AM
03:11PM
Loading…
Mar-31-25 03:11PM
09:06AM
08:09AM
Mar-26-25 09:15AM
Mar-18-25 07:59PM
Mar-13-25 07:28AM
Mar-12-25 08:30AM
Mar-05-25 02:10AM
Mar-04-25 05:35PM
04:10PM
Mar-03-25 07:18AM
Feb-18-25 08:30AM
Jan-21-25 08:30AM
Jan-14-25 08:30AM
Jan-06-25 08:30AM
08:30AM
Loading…
Nov-12-24 08:30AM
Nov-08-24 04:03PM
Nov-07-24 05:55PM
04:05PM
Nov-06-24 07:37AM
Oct-31-24 10:01AM
Oct-29-24 08:30AM
Oct-22-24 08:30AM
Oct-21-24 08:30AM
Oct-15-24 08:30AM
Oct-07-24 08:30AM
Sep-25-24 08:30AM
Sep-09-24 05:28AM
Aug-19-24 03:27AM
Aug-06-24 07:00PM
04:15PM
04:05PM
Jul-23-24 08:30AM
Jul-12-24 02:46AM
Jul-09-24 09:35AM
Jun-20-24 08:30AM
May-17-24 02:33AM
May-08-24 02:54PM
04:03AM
May-07-24 09:56PM
06:18PM
04:08PM
May-03-24 10:12AM
06:41AM
Apr-30-24 08:30AM
Apr-25-24 10:02AM
Mar-13-24 09:16AM
Mar-12-24 05:52PM
05:30PM
04:05PM
Feb-27-24 08:30AM
Feb-15-24 10:00AM
Feb-13-24 09:55AM
Nov-27-23 08:30AM
Nov-21-23 03:26PM
Nov-16-23 08:30AM
Nov-09-23 05:23PM
Nov-08-23 06:05PM
04:05PM
Nov-02-23 08:30AM
Oct-26-23 10:02AM
Oct-25-23 08:30AM
Oct-12-23 08:30AM
Oct-10-23 08:30AM
Oct-09-23 04:05PM
Sep-14-23 08:30AM
Aug-10-23 07:14AM
Aug-09-23 05:30PM
04:05PM
Aug-02-23 08:30AM
Jul-31-23 08:53AM
Jul-23-23 08:17AM
Jul-13-23 12:24PM
11:17AM
Jul-12-23 04:05PM
12:56PM
Jun-29-23 08:39AM
May-25-23 08:02AM
May-12-23 07:15AM
May-04-23 06:05PM
04:05PM
Apr-27-23 10:02AM
08:30AM
Apr-25-23 08:30AM
Apr-01-23 08:54AM
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
SHELTON JERRELL President, CEO Jun 25 '25 Option Exercise 5.00 25,000 125,000 937,419 Jun 26 08:00 PM SHELTON JERRELL President, CEO Jun 24 '25 Option Exercise 5.00 16,344 81,720 928,763 Jun 26 08:00 PM SHELTON JERRELL President, CEO Jun 24 '25 Sale 7.06 16,344 115,366 912,419 Jun 26 08:00 PM Mandalam Ramkumar Director Jun 24 '25 Option Exercise 3.07 20,000 61,400 86,377 Jun 26 08:00 PM Mandalam Ramkumar Director Jun 24 '25 Sale 7.01 13,321 93,447 73,056 Jun 26 08:00 PM RAMKUMAR MANDALAM Director Jun 24 '25 Proposed Sale 6.56 13,321 87,386 Jun 24 04:09 PM SHELTON JERRELL President, CEO Jun 17 '25 Option Exercise 5.00 201,304 1,006,520 1,063,723 Jun 20 08:15 PM SHELTON JERRELL President, CEO Jun 18 '25 Option Exercise 5.00 119,281 596,405 1,031,700 Jun 20 08:15 PM SHELTON JERRELL President, CEO Jun 20 '25 Option Exercise 5.00 69,135 345,675 981,554 Jun 20 08:15 PM SHELTON JERRELL President, CEO Jun 17 '25 Sale 6.81 151,304 1,029,715 912,419 Jun 20 08:15 PM SHELTON JERRELL President, CEO Jun 18 '25 Sale 6.81 119,281 812,542 912,419 Jun 20 08:15 PM SHELTON JERRELL President, CEO Jun 20 '25 Sale 6.47 69,135 447,525 912,419 Jun 20 08:15 PM JERRELL W SHELTON Director Jun 17 '25 Proposed Sale 6.93 356,064 2,467,524 Jun 17 04:14 PM Mandalam Ramkumar Director Jun 11 '25 Sale 7.06 8,193 57,816 68,896 Jun 13 07:00 PM Mandalam Ramkumar Director Jun 12 '25 Sale 7.01 1,895 13,286 67,001 Jun 13 07:00 PM Mandalam Ramkumar Director Jun 13 '25 Sale 6.80 624 4,246 66,377 Jun 13 07:00 PM RAMKUMAR MANDALAM Director Jun 13 '25 Proposed Sale 6.80 624 4,246 Jun 13 04:12 PM RAMKUMAR MANDALAM Director Jun 12 '25 Proposed Sale 7.01 1,895 13,286 Jun 12 04:18 PM RAMKUMAR MANDALAM Director Jun 11 '25 Proposed Sale 7.01 8,193 57,463 Jun 11 04:21 PM ZECCHINI EDWARD J Chief Digital and Tech Officer Jun 10 '25 Option Exercise 3.07 75,000 230,250 141,911 Jun 10 07:28 PM ZECCHINI EDWARD J Chief Digital and Tech Officer Jun 10 '25 Sale 6.84 51,500 352,518 90,411 Jun 10 07:28 PM Mandalam Ramkumar Director Jun 09 '25 Sale 7.06 5,622 39,673 77,089 Jun 10 07:25 PM EDWARD ZECCHINI Officer Jun 10 '25 Proposed Sale 6.84 51,500 352,512 Jun 10 04:29 PM RAMKUMAR MANDALAM Director Jun 09 '25 Proposed Sale 7.06 5,622 39,673 Jun 09 05:33 PM SHELTON JERRELL President, CEO Jun 04 '25 Option Exercise 5.00 50,000 250,000 862,419 Jun 06 02:21 PM Hariri Robert J Director May 28 '25 Sale 6.10 12,500 76,250 8,061 May 30 07:00 PM Sawicki Mark W Chief Scientific Officer Mar 24 '25 Sale 6.94 1,349 9,364 84,087 Mar 26 07:01 PM STEFANOVICH ROBERT Chief Financial Officer Mar 24 '25 Sale 6.94 1,070 7,428 190,349 Mar 26 07:00 PM SHELTON JERRELL President, CEO Mar 24 '25 Sale 6.94 2,980 20,686 762,419 Mar 26 07:00 PM ZECCHINI EDWARD J Chief Digital and Tech Officer Mar 17 '25 Sale 6.29 1,140 7,173 66,911 Mar 18 07:08 PM STEFANOVICH ROBERT Chief Financial Officer Mar 17 '25 Sale 6.29 1,659 10,438 191,419 Mar 18 07:07 PM Sawicki Mark W Chief Scientific Officer Mar 17 '25 Sale 6.29 2,092 13,162 85,436 Mar 18 07:06 PM SHELTON JERRELL President, CEO Mar 17 '25 Sale 6.29 4,620 29,068 765,399 Mar 18 07:05 PM Sawicki Mark W Chief Scientific Officer Mar 09 '25 Option Exercise 0.00 2,667 0 80,111 Mar 11 07:01 PM Sawicki Mark W Chief Scientific Officer Mar 10 '25 Sale 4.88 1,583 7,724 78,528 Mar 11 07:01 PM SHELTON JERRELL President, CEO Mar 09 '25 Option Exercise 0.00 8,250 0 744,192 Mar 11 07:01 PM SHELTON JERRELL President, CEO Mar 10 '25 Sale 4.88 4,173 20,360 740,019 Mar 11 07:01 PM STEFANOVICH ROBERT Chief Financial Officer Mar 09 '25 Option Exercise 0.00 2,667 0 184,334 Mar 11 07:00 PM STEFANOVICH ROBERT Chief Financial Officer Mar 10 '25 Sale 4.88 1,256 6,128 183,078 Mar 11 07:00 PM STEFANOVICH ROBERT Chief Financial Officer Dec 11 '24 Option Exercise 4.80 53,334 256,003 181,667 Dec 13 06:13 PM Mandalam Ramkumar Director Dec 02 '24 Option Exercise 4.80 10,834 52,003 66,866 Dec 04 07:00 PM Mandalam Ramkumar Director Dec 02 '24 Sale 7.46 7,369 54,978 59,497 Dec 04 07:00 PM Hariri Robert J Director Nov 21 '24 Sale 6.48 2,500 16,200 20,561 Dec 02 07:00 PM RAMKUMAR MANDALAM Director Dec 02 '24 Proposed Sale 7.08 7,369 52,173 Dec 02 04:43 PM SHELTON JERRELL President, CEO Nov 21 '24 Option Exercise 4.80 59,150 283,920 781,897 Nov 25 07:00 PM SHELTON JERRELL President, CEO Nov 22 '24 Option Exercise 4.80 26,862 128,938 758,759 Nov 25 07:00 PM SHELTON JERRELL President, CEO Nov 21 '24 Sale 6.51 50,000 325,275 731,897 Nov 25 07:00 PM SHELTON JERRELL President, CEO Nov 22 '24 Sale 6.47 22,817 147,612 735,942 Nov 25 07:00 PM JERRELL W SHELTON Director Nov 22 '24 Proposed Sale 6.52 22,817 148,767 Nov 22 04:31 PM SHELTON JERRELL President, CEO Nov 19 '24 Option Exercise 4.80 60,440 290,112 762,747 Nov 20 07:57 PM SHELTON JERRELL President, CEO Nov 18 '24 Option Exercise 4.80 60,215 289,032 752,307 Nov 20 07:57 PM SHELTON JERRELL President, CEO Nov 20 '24 Option Exercise 4.80 60,000 288,000 772,747 Nov 20 07:57 PM SHELTON JERRELL President, CEO Nov 19 '24 Sale 6.78 50,000 338,985 712,747 Nov 20 07:57 PM SHELTON JERRELL President, CEO Nov 18 '24 Sale 6.73 50,000 336,540 702,307 Nov 20 07:57 PM SHELTON JERRELL President, CEO Nov 20 '24 Sale 6.65 50,000 332,295 722,747 Nov 20 07:57 PM JERRELL W SHELTON Director Nov 20 '24 Proposed Sale 6.93 100,000 693,500 Nov 20 04:33 PM JERRELL W SHELTON Director Nov 19 '24 Proposed Sale 6.70 50,000 335,000 Nov 19 04:30 PM JERRELL W SHELTON Director Nov 18 '24 Proposed Sale 6.99 50,000 349,500 Nov 18 05:14 PM Hariri Robert J Director Aug 19 '24 Sale 9.46 1,000 9,465 23,061 Aug 26 07:11 PM Hariri Robert J Director Aug 16 '24 Sale 9.00 1,000 9,000 23,561 Aug 20 05:28 PM Hariri Robert J Director Aug 14 '24 Sale 8.40 1,000 8,395 24,561 Aug 20 05:28 PM Mandalam Ramkumar Director Aug 02 '24 Option Exercise 5.04 4,167 21,002 60,199 Aug 06 08:00 PM Mandalam Ramkumar Director Aug 02 '24 Sale 8.04 4,167 33,520 56,032 Aug 06 08:00 PM RAMKUMAR MANDALAM Director Aug 02 '24 Proposed Sale 8.70 4,167 36,253 Aug 02 04:22 PM